As part of its sweeping $1.5 billion cost-cutting measure, Bristol Myers Squibb is culling “about 12” programs from its pipeline, CMO Samit Hirawat said Thursday morning.
The programs will either be discontinued or externalized as Bristol Myers slashes costs company-wide in Chris Boerner’s first major move as chief executive. Thursday’s announcement also included about 2,200 job cuts, representing approximately 6% of its global workforce.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.